z-logo
Premium
Synthesis of [ 14 C]‐labelled repinotan hydrochloride and its major metabolite M‐6
Author(s) -
Seidel D.,
Conrad M.,
Schoof Y.,
SchoheLoop R.
Publication year - 2002
Publication title -
journal of labelled compounds and radiopharmaceuticals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 47
eISSN - 1099-1344
pISSN - 0362-4803
DOI - 10.1002/jlcr.629
Subject(s) - chemistry , moiety , acetophenone , hydrochloride , metabolite , phenol , yield (engineering) , stereochemistry , ring (chemistry) , carbon 14 , chemical synthesis , medicinal chemistry , organic chemistry , catalysis , in vitro , biochemistry , materials science , physics , quantum mechanics , metallurgy
For studies of pharmacokinetics and drug metabolism of the new 5‐HT 1A agonist repinotan, the 14 C‐labelled version was synthesized. Starting from [U‐ 14 C]phenol, a 10‐step synthesis led to 457 mg (1.58 GBq) of [U‐ 14 C]repinotan hydrochloride, labelled uniformly in the aromatic ring of the chromane moiety. For a study in man, a mono‐carbon‐14 labelled substance was required. Therefore a 7‐step synthesis was performed starting from [carbonyl‐ 14 C]2‐hydroxy‐acetophenone. The yield was 106 mg (0.396 GBq) of [4‐chromane‐ 14 C]repinotan hydrochloride. The carbon‐14 labelled major metabolite, hydroxylated in the 6‐position of the chromane moiety, was synthesised as reference compound. Copyright © 2002 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom